Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Acura Pharmaceuticals Inc
ACURCurrent price
0.0016 USD
0 USD (0.00%)
Last closed
0.0015 USD
Company
www.acurapharm.com
ISIN
US00509L8028
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
OTCQB
Capitalization
99 002 USD
Yield for 12 month
+433.33 %
1Y
3Y
5Y
10Y
15Y
ACUR
Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc. and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was formerly known as Halsey Drug Co., Inc. The company was incorporated in 1935 and is based in Palatine, Illinois. Acura Pharmaceuticals, Inc. operates as a subsidiary of Abuse Deterrent Pharma, LLC. Address: 616 N. North Court, Palatine, IL, United States, 60067
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
6 USDP/E ratio
–Dividend Yield
–Current Year
+1 563 000 USD
Last Year
+3 570 000 USD
Current Quarter
+270 000 USD
Last Quarter
+613 000 USD
Current Year
–
Last Year
+3 570 000 USD
Current Quarter
–
Last Quarter
+613 000 USD
Key Figures ACUR
1 year
3 years
5 years
10 years
EBITDA
-1 141 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-58.46 %
PEG Ratio
–
Return On Equity TTM
–
Wall Street Target Price
6 USD
Revenue TTM
1 563 000 USD
Book Value
0.003 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-95 %
Dividend Yield
–
Gross Profit TTM
39 000 USD
Earnings per share
-0.02 USD
Diluted Eps TTM
-0.02 USD
Most Recent Quarter
III 2021
Quarterly Earnings Growth YOY
–
Profit Margin
-56.24 %
Dividend Analytics ACUR
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ACUR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:5
Payout Ratio
–
Last Split Date
28.08.2015
Dividend Date
–
Stock Valuation ACUR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.1497
Price Sales TTM
0.0633
Enterprise Value EBITDA
-4.6096
Price Book MRQ
0.5562
Financials ACUR
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ACUR
For 52 weeks
0.0001 USD
0.05 USD
50 Day MA
0.0029 USD
Shares Short Prior Month
76 004
200 Day MA
0.0089 USD
Short Ratio
0.73
Shares Short
89 846
Short Percent
1.2 %
BeatStart